![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 51, 53116-53125, December 17, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Hollings Cancer Center, the Medical University of South Carolina, Charleston, South Carolina 29425
We find that phorbol ester (PE) treatment of K562 cells greatly stimulates promoters (T cell receptor
, myeloperoxidase, macrophage colony-stimulating factor receptor, and granulocyte macrophage colony-stimulating factor receptor) containing AML1 transcription factor binding sites. This stimulation of AML1c transcriptional activity is mediated by direct phosphorylation of the AML1c molecule on multiple phosphorylation sites. Eleven AML1c (S/T)P sites in the transcriptional activating domain are phosphorylated at a basal level in untreated K562 cells; treatment of the K562 cells with PE results in increased phosphorylation at five of these sites (serines 276, 293, 303, 462, and threonine 300). Mutation of these five sites to alanine inhibits PE-induced transcriptional activity; mutation of the sites to an acidic amino acid, aspartic acid, stimulates constitutive activity. Single mutations in four amino acids or double mutations (serines 276 and 293 or threonine 300 and serine 303) have little effect on AML1c transcriptional activity. Inhibitor assays suggest that the ERK family of protein kinases is activated by PEs to phosphorylate the (S/T)P sites within the AML1c molecule and markedly enhance the transcriptional activity of AML1c.
Received for publication, May 17, 2004 , and in revised form, September 30, 2004.
* This work was supported by National Institutes of Health Grant CA42533 (to A. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037.
To whom correspondence should be addressed: Hollings Cancer Center, the Medical University of South Carolina, 86 Jonathan Lucas St., Charleston, SC 29425. Tel.: 843-792-8284; Fax: 843-792-9456; E-mail: Kraft{at}musc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Zhang, F. B. Fried, H. Guo, and A. D. Friedman Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation Blood, February 1, 2008; 111(3): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Biggs, L. F. Peterson, Y. Zhang, A. S. Kraft, and D.-E. Zhang AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex Mol. Cell. Biol., October 15, 2006; 26(20): 7420 - 7429. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yuan, A. Tie, M. Tarnopolsky, and M. Bakovic Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1 Physiol Genomics, September 14, 2006; 26(1): 76 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hamelin, C. Letourneux, P.-H. Romeo, F. Porteu, and M. Gaudry Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation Blood, April 15, 2006; 107(8): 3106 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Phillips, C. A. Gersbach, A. M. Wojtowicz, and A. J. Garcia Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation J. Cell Sci., February 1, 2006; 119(3): 581 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, Y. Zhang, J. R. Biggs, D.-E. Zhang, and A. S. Kraft Phosphorylation of AML1 (RUNX1) Controls Transcription, Nuclear Localization, and Is Regulated during DNA Damage. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 2712 - 2712. [Abstract] |
||||
![]() |
J. R. Biggs, Y. Zhang, L. F. Peterson, M. Garcia, D.-E. Zhang, and A. S. Kraft Phosphorylation of AML1/RUNX1 Regulates Its Degradation and Nuclear Matrix Association Mol. Cancer Res., July 1, 2005; 3(7): 391 - 401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |